For research use only. Not for therapeutic Use.
Voxalatamab (JNJ-63898081) is a bispecific IgG4 antibody that binds PSMA and CD3 and has anti-cancer activity for use in prostate cancer research[1].
| Catalog Number | I042137 |
| CAS Number | 2411871-58-2 |
| Purity | ≥95% |
| Reference | [1]. Jonas S Heitmann, et al. Bispecific Antibodies in Prostate Cancer Therapy: Current Status and Perspectives. Cancers (Basel). 2021 Feb 1;13(3):549. |
